LEXARIA BIOSCIENCE CORP. Interest Income, Other
LEXARIA BIOSCIENCE CORP. (LEXX) reported Interest Income, Other of $837 for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. interest income, other for the quarter ending 2026-05-31 was $837.00, a 340.53% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. interest income, other for the quarter ending 2026-02-28 was $1.77K.
- LEXARIA BIOSCIENCE CORP. interest income, other for the quarter ending 2025-11-30 was $12.00, a 9.09% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. interest income, other for the quarter ending 2025-08-31 was $2.82K, a 59.73% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. interest income, other for fiscal 2025 was $3.02K, a 78.92% decline from fiscal 2024.
- LEXARIA BIOSCIENCE CORP. interest income, other for fiscal 2024 was $14.31K, a 66.87% decline from fiscal 2023.
- LEXARIA BIOSCIENCE CORP. interest income, other for fiscal 2023 was $43.19K, a 48.62% increase from fiscal 2022.
- LEXARIA BIOSCIENCE CORP. interest income, other for fiscal 2022 was $29.06K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month | Interest Income, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $837.00 10-Q · filed 2026-07-13 | $2.61K derived: sum of 2 quarters · filed 2026-07-13 | $2.62K 10-Q · filed 2026-07-13 | $5.43K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2026-02-28 | $1.77K 10-Q · filed 2026-04-13 | $1.78K 10-Q · filed 2026-04-13 | $4.60K derived: sum of 3 quarters · filed 2026-04-13 | $4.79K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2025-11-30 | $12.00 10-Q · filed 2026-01-13 | $2.83K derived: sum of 2 quarters · filed 2026-01-13 | $3.02K derived: sum of 3 quarters · filed 2026-07-13 | $3.02K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2025-08-31 | $2.82K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $3.01K derived: sum of 2 quarters · filed 2026-07-13 | $3.01K derived: sum of 3 quarters · filed 2026-07-13 | $3.02K 10-K · filed 2025-11-28 | |
| 2025-05-31 | $190.00 10-Q · filed 2026-07-13 | $190.00 derived: sum of 2 quarters · filed 2026-07-13 | $201.00 10-Q · filed 2026-07-13 | $7.19K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2025-02-28 | $0.00 10-Q · filed 2026-04-13 | $11.00 10-Q · filed 2026-04-13 | $7.00K derived: sum of 3 quarters · filed 2026-04-13 | $7.00K derived: sum of 4 quarters · filed 2026-04-13 | |
| 2024-11-30 | $11.00 10-Q · filed 2026-01-13 | $7.00K derived: sum of 2 quarters · filed 2026-01-13 | $7.00K derived: sum of 3 quarters · filed 2026-01-13 | ||
| 2024-08-31 | $6.99K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $6.99K derived: sum of 2 quarters · filed 2025-11-28 | $14.31K 10-K · filed 2025-11-28 | $14.12K 10-K · filed 2024-11-26 | |
| 2024-05-31 | $0.00 10-Q · filed 2025-07-14 | $7.32K 10-Q · filed 2025-07-14 | |||
| 2023-11-30 | $7.32K 10-Q · filed 2025-01-10 | ||||
| 2023-08-31 | $43.19K 10-K · filed 2023-11-20 | ||||
| 2022-08-31 | $29.06K 10-K · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |